After years of delay, topical dapsone gel 5% can now be prescribed for patients with mild to moderate acne, marking the first new chemically based drug treatment for acne in a decade. A sulfone drug, ...

Feb. 22, 2005 (New Orleans) -- A new topical gel containing 5% dapsone is showing promise in the treatment of acne vulgaris, according to results from two studies reported here at the 63rd annual ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. (“Cosette”), in partnership with SeegPharm SA (Lugano, Switzerland), is proud to announce the launch of Dapsone 5% Gel (NDC # ...

The U.S. Food and Drug Administration (FDA) has recalled 23,304 bottles of Dapsone Gel 7.5%, a popular prescription acne treatment sold under brands like Nurx and Aczone. This topical antibiotic is ...

DUBLIN, Sept. 26, 2017 /PRNewswire/ -- Today, Allergan plc (NYSE: AGN) is pleased to announce that ACZONE ® (dapsone) Gel, 7.5%, a prescription medicine used on the skin (topical) to treat acne in ...

Allergan announced the discontinuation of Aczone (dapsone) 5% 30g tubes. Allergan announced the discontinuation of Aczone (dapsone) 5% 30g tubes. The last ship date was March 31, 2016 and the ...

The Food and Drug Administration (FDA) has approved Aczone (dapsone; Almirall) Gel 7.5% for the topical treatment of acne vulgaris in patients aged ≥9 years. Previously, the treatment had been ...

The FDA has approved a new gel to treat acne. Aczone Gel 5%, made by QLT Inc., is approved to treat acne vulgaris. That's a common skin condition in which oil and dead skin cells clog the skin's pores ...

ACZONE gel 5% is the only acne treatment to harness the potential of dapsone in a topical formulation to provide patients with a convenient and effective therapy. QLT owns worldwide marketing rights ...

NEW YORK (Reuters Health) - The results of two pivotal studies demonstrate that a topical antibiotic gel sold as Aczone is safe and effective against severe blemishes and pimples go along with being a ...

Launch continues the expansion of Cosette’s generic portfolio and global partnership strategy BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. (“Cosette”), in partnership with ...